Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sheel BiotechNSE:SHEEL 18 Net Margin % is 10.69% as of Mar. 2026, which is 1% above its 10-year median of 10.57. GuruFocus rates NSE:SHEEL with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Sheel Biotech ranks better than 81.77% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Sheel Biotech's Net Income for the
six
months ended in Mar. 2026 was ₹118 Mil. Sheel Biotech's Revenue for the
six
months ended in Mar. 2026 was ₹1,100 Mil. Therefore, Sheel Biotech's net margin for the quarter that ended in Mar. 2026 was 10.69%.
The historical rank and industry rank for Sheel Biotech's Net Margin % or its related term are showing as below:
NSE:SHEEL'
s Net Margin % Range Over the Past 10 Years
Min: 6.34 Med: 10.57 Max: 11.35
Current: 10.69
NSE:SHEEL's Net Margin % is ranked better than 81.77% of 1953
companies
in the Consumer Packaged Goods industry
Industry Median: 3.51
vs NSE:SHEEL: 10.69
Sheel Biotech (NSE:SHEEL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sheel Biotech Net Margin % Related Terms
Sheel Biotech Net Margin % Historical Data
* Premium members only.
The historical data trend for Sheel Biotech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech Net Margin % Chart
Sheel Biotech Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Net Margin %
6.38
6.34
11.35
10.57
10.69
Sheel Biotech Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Net Margin %
6.38
6.34
11.35
10.57
10.69
NSE:SHEEL vs ADM, BG, TSN: Net Margin % Comparison
For the Farm Products subindustry, Sheel Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sheel Biotech Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sheel Biotech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sheel Biotech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sheel Biotech (NSE:SHEEL) has a Net Margin % of 10.69% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sheel Biotech and its competitors. This is near median its historical median of 10.57. Over the past decade, Sheel Biotech's Net Margin % has ranged from 6.34 to 11.35. According to the industry distribution chart, Sheel Biotech ranks #356 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 18.2%.
Is Sheel Biotech's Net Margin % too high?
Sheel Biotech's current Net Margin % of 10.69% is near median its 10-year median of 10.57. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 11.35. The Consumer Packaged Goods industry median Net Margin % is 3.51. Sheel Biotech's value of 10.69% is 204.6% above this industry median. Based on the distribution chart, Sheel Biotech ranks #356 out of 1953 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Sheel Biotech has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Net Margin % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Sheel Biotech ranks #356 out of 1953 companies for Net Margin %. This places Sheel Biotech in the top 18% of its industry — outperforming the majority of peers. The industry median Net Margin % is 3.51. Sheel Biotech's value of 10.69% is 204.6% above this benchmark. Historically, Sheel Biotech's own Net Margin % has ranged from 6.34 to 11.35 over the past decade. While the company's 10-year median is 10.57 vs. the industry median of 3.51, Sheel Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.51, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sheel Biotech's current Net Margin % of 10.69% is 204.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sheel Biotech and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sheel Biotech's current Net Margin % is 10.69%, which is near median its own 10-year median of 10.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Net Margin % of 10.69%. The current Net Margin % is 10.69%, which is near median its 10-year median of 10.57 and 204.6% above the Consumer Packaged Goods industry median of 3.51. Sheel Biotech's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Net Margin % is 10.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
18GF Score
Get the complete analysis for NSE:SHEEL
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHEEL has been successfully added to your 
